DK0688565T4 - Metode til fremstilling af tabletter, kapsler eller granulatkorn indeholdende desogestrel - Google Patents

Metode til fremstilling af tabletter, kapsler eller granulatkorn indeholdende desogestrel

Info

Publication number
DK0688565T4
DK0688565T4 DK95201495T DK95201495T DK0688565T4 DK 0688565 T4 DK0688565 T4 DK 0688565T4 DK 95201495 T DK95201495 T DK 95201495T DK 95201495 T DK95201495 T DK 95201495T DK 0688565 T4 DK0688565 T4 DK 0688565T4
Authority
DK
Denmark
Prior art keywords
capsules
granules containing
desogestrel
preparing tablets
containing desogestrel
Prior art date
Application number
DK95201495T
Other languages
English (en)
Other versions
DK0688565T3 (da
Inventor
Haan Pieter De
Johannes G J Egberink
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0688565(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK0688565T3 publication Critical patent/DK0688565T3/da
Publication of DK0688565T4 publication Critical patent/DK0688565T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95201495T 1994-06-08 1995-06-07 Metode til fremstilling af tabletter, kapsler eller granulatkorn indeholdende desogestrel DK0688565T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201625 1994-06-08

Publications (2)

Publication Number Publication Date
DK0688565T3 DK0688565T3 (da) 2004-03-29
DK0688565T4 true DK0688565T4 (da) 2008-03-17

Family

ID=8216929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95201495T DK0688565T4 (da) 1994-06-08 1995-06-07 Metode til fremstilling af tabletter, kapsler eller granulatkorn indeholdende desogestrel

Country Status (18)

Country Link
US (1) US5709881A (da)
EP (1) EP0688565B2 (da)
JP (1) JP4302783B2 (da)
KR (1) KR100380841B1 (da)
CN (1) CN1057673C (da)
AT (1) ATE254921T1 (da)
AU (1) AU697512B2 (da)
BR (1) BR9502704A (da)
CA (1) CA2150642C (da)
DE (1) DE69532176T3 (da)
DK (1) DK0688565T4 (da)
ES (1) ES2210272T5 (da)
FI (1) FI952765A7 (da)
HU (1) HU218282B (da)
IL (1) IL113816A (da)
NZ (1) NZ272285A (da)
PT (1) PT688565E (da)
RU (1) RU2160107C2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
EP1204410B1 (en) * 1999-07-30 2012-09-12 Capsugel Belgium NV Multi-component pharmaceutical dosage form
WO2003004001A1 (en) * 2001-07-06 2003-01-16 Lifecycle Pharma A/S Controlled agglomeration
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
CN105030792B (zh) * 2015-06-30 2017-08-25 上海交通大学 Desogestrel在制备抗结肠癌/ER阴性的Ah受体阳性的乳腺癌产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140915A (en) † 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
EP0300523B1 (en) 1987-07-06 1991-08-14 Akzo N.V. Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5395627A (en) † 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate

Also Published As

Publication number Publication date
RU2160107C2 (ru) 2000-12-10
JP4302783B2 (ja) 2009-07-29
KR100380841B1 (ko) 2003-08-14
DE69532176D1 (de) 2004-01-08
NZ272285A (en) 1996-08-27
EP0688565B2 (en) 2007-11-21
HUT71491A (en) 1995-11-28
IL113816A (en) 1998-12-06
CA2150642C (en) 2008-04-22
CN1122226A (zh) 1996-05-15
ES2210272T3 (es) 2004-07-01
FI952765A0 (fi) 1995-06-06
HU9501654D0 (en) 1995-07-28
PT688565E (pt) 2004-03-31
AU697512B2 (en) 1998-10-08
ATE254921T1 (de) 2003-12-15
ES2210272T5 (es) 2008-05-01
KR960000231A (ko) 1996-01-25
DE69532176T2 (de) 2004-08-12
AU2053195A (en) 1995-12-14
DE69532176T3 (de) 2008-06-12
DK0688565T3 (da) 2004-03-29
EP0688565A1 (en) 1995-12-27
HU218282B (en) 2000-07-28
US5709881A (en) 1998-01-20
EP0688565B1 (en) 2003-11-26
CA2150642A1 (en) 1995-12-09
CN1057673C (zh) 2000-10-25
HK1001996A1 (en) 1998-07-24
JPH07330610A (ja) 1995-12-19
BR9502704A (pt) 1996-03-05
FI952765L (fi) 1995-12-09
IL113816A0 (en) 1995-08-31
FI952765A7 (fi) 1995-12-09

Similar Documents

Publication Publication Date Title
DK0489647T3 (da) N,O-sulfaterede heparosaner, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser.
ATE48598T1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alk nsaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ATE46900T1 (de) Phenylethanolaminotetraline, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3750913D1 (de) Karbostyrilderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung.
DE3852145D1 (de) Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten.
ATE66224T1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE68901039D1 (de) Indolylpiperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische verbindungen.
DK0688565T4 (da) Metode til fremstilling af tabletter, kapsler eller granulatkorn indeholdende desogestrel
DK102990A (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
ATE15196T1 (de) N-substituierte 2-pyridylindole, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
DE58909594D1 (de) 6-Oxo-pyridazinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
DE3787319D1 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
LU84492A1 (de) Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate
DE3672832D1 (de) Ringsubstituierte alpha-(alkylaminopropionyl)-thiophen-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK365087D0 (da) 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
ATE73131T1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE55126T1 (de) Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE12640T1 (de) Imidazolin-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zusammensetzungen und ihre verwendung.
ATE13766T1 (de) Ergolin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE13293T1 (de) Verbindungen, als entzuendungshemmendes mittel und als hustenmittel wirksam, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3667663D1 (de) Nitrosubstituierte heteroarylverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE50579T1 (de) Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.